Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

WELL Health Technologies Corp T.WELL

Alternate Symbol(s):  WHTCF | T.WELL.DB

WELL Health Technologies Corp. is a practitioner-focused digital healthcare company. The Company develops technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. Its business units include Canadian Patient Services, WELL Health USA Patient Services and SaaS and Technology Services. WELL Health USA Patient and Provider Services includes Primary Circle Medical, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing. Its healthcare and digital platform includes front and back-office management software applications that help physicians run and secure their practices. Its focused markets include the gastrointestinal market, women's health, primary care and mental health. Its solutions enable 34,000 healthcare providers between the United States and Canada and power owned and operated healthcare’s in Canada with 165 clinics supporting primary care, specialized care and diagnostic services.


TSX:WELL - Post by User

Comment by jdsd0517on May 04, 2022 8:41pm
116 Views
Post# 34657207

RE:RE:RE:RE:RE:RE:The Goodwill Ran Out

RE:RE:RE:RE:RE:RE:The Goodwill Ran OutThat's not correct. 

According to IFRS, the value is crystalized on the acquisition date according to the value of the consideration transferred, regardless of whether consideration was in stock or cash.

On your other points (not included in the quote below), the test for the writedown of goodwill is whether the "value in use" of the asset exceeds its carrying value, where "value in use" is based on expected future cash flows from the asset.  The value of stock doesn't have any bearing on the calculation.

Capharnaum wrote:
That said, if the purchase was done with $ instead of stock, then it cristallizes the value for the acquirer. So, in general, acquisitions should be done with shares when the acquirer's valuation metrics are high, and vice versa.


<< Previous
Bullboard Posts
Next >>